FDA Investigator Jennifer L Johnson
Jennifer L Johnson has inspections in 2 countries as of 24 May 2023. Jennifer L Johnson has collaborated with a combinined 3445 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
85
Last Inspection Date:
24 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada,
United States of America
Co-Investigator(s):
Adam S Freeman,
Alex G Kalugin,
Alla Dubrovsky,
Amanda N Schaupp,
Andersoneric,
Andrew B Slarve,
Andrew E Kay,
Andrew K Haack, PhD,
Andrew T Todd,
Angel K Sandhu,
Angela D Wise,
Anh M Lac,
Anna L Viveros Hernandez,
Annie H Lam,
Arindam Dasgupta, PhD,
Ashar P Parikh,
Bak,
Beverley A Phillips,
Blair,
Breena L D'ambrogi,
Brian R Henderson,
Brian R Yaun,
Bruce,
Bruce D Broidy,
Bryan S Roddy,
Camacho,
Capri R Woolridge,
Carl Lee,
Carr,
Catherine D Djordjevic,
CDR Rochelle B Young, RPh, MSA,
Celeste K Wong,
Chan,
Charles E Frelix,
Charles M Spyr,
Christine M Parmentier,
Christopher Do,
Christopher J Lee,
Cindy W Lewis,
Courtney R Bolton,
Cynthia L Ford,
Damon A Growl,
Dana A Razzano,
Daniel J Gorski,
Daniel J Roberts,
Daniel Velasquez,
Darla R Bracy,
David A Laplante,
David A Lum,
David A Paterson,
David G Eng,
David J Leray,
Deborah K Richardson,
Dena L Jacobs,
Diane Cvan Leeuwen,
Diyo R Rai,
Downer,
Dustin P Tran,
Dustin R Abaonza,
Edna J Hidalgo,
Edwardstine J Reese,
Elaine S Chow,
Elisabeth A Drevet,
Elodie Xtong Lin,
Emal Wahab,
Emmanuel O Kerry,
Erica R Pomeroy,
Estefania Fernandez,
Frank P Bianco,
Gina M Hall,
Hans T Meyers,
Helen J Hamaoka,
Henry K Lau,
Huy T Pham,
Ifueko Osemwota,
Ingrid A Zambrana,
Ismael Garibay,
James C Lee, PharmD,
James C Yee,
James S Cartwright,
Jane G Choi,
Janice Wai,
Jannifer L Degroot,
Jazmine M Welcher,
Jeanne A Young,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer Crumb,
Jennifer I Johnson,
Jennifer L Degroot,
Jennifer R Johnson,
Jennifer S King,
Joan T Briones,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Gonzalez,
John A Liu,
John N Woodall,
John R Myung,
Jorge L Bertran,
Joseph A Seitz,
Joseph Tibay,
Joshua M Adams,
Juan A Morales,
Jude C Dikes,
Juliane Kjung Lau,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Karen L Robles,
Karla J Gibler,
Kawshalya Pathiraja,
Kenneth O Gee, PhD,
Keren Arkin,
Kevin P Foley,
Kim Lthomas Cruse,
Kristin M Abaonza,
Lance M De Souza, MBA,
Larkin R Buckalew,
LCDR Jennifer H Rhyu,
Lea Lakes,
Lee,
Leongc,
Ligia M Cline,
Lija V Fellows,
Lilly O Barton,
Linda Linh T Nguyen,
Linda S Shook,
Lisa H Nakagawa,
Liu,
Lorraine N Williams,
Lourdes Andujar,
LT Mark A Chen, MPH,
Lucila B Nwatu,
Luis A Solorzano,
Lydia S Chan,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Mancia R Walker,
Maridali De Leon Torres,
Marie K Kinkade,
Marissa J Chan,
Mark I Nakano,
Marshalette O Edwards,
Martin R Vowell,
Mary C Acton,
Mary C Wall,
Mary K Kinkade,
Mary R Hole,
Matthew K Wong,
Mcgrewp,
Melody M Ragasa Leong,
Michele R Douglas,
Michelle L Tripp,
Monique C Lo,
Nicholas L Hunt,
Nicole Yuen,
Nina D Patel,
Nympha V Florendo,
Pablo Alcantara,
Patrick B Cummings,
Paula P Demichael,
Peter E Baker,
Phillip J Sample,
Phung,
Quynh H Strandberg,
Rafeeq A Habeeb,
Randall J Plunkett,
Randall P Zielinski,
Raymond T Oji,
Rebecca E Sulpacio,
Roberta K Smith,
Robles,
Roger D Gawne,
Ronald P Boyce,
Roy C Stephens,
Rumany C Penn, PharmD,
Sandra S Saniga,
Scott N Lim,
Scott W Fox,
Sean P Desbrow,
Seema S Singh,
Sergio Chavez (NMI),
Sharon K Thoma, PharmD,
Sharon K Thomas,
Sharon L Shane,
Siobhan A Gallagher,
State Agency,
Stephanie A Slater, MS,
Steven C Himebaugh,
Steven M Galvez,
Stuart W Russell,
Tamayo C Barnes,
Terrence Gee,
Thea C Grome,
Thomas N Adjabeng,
Thomas W Gordon,
Tiffany Chao,
Timothy C Grome,
Tressa T Lewis,
Uduak M Inokon,
Vi T Au,
Victoria L Morgan,
Walden H Lee,
Wen Jun Peng,
Willemsj,
William J Foust,
William J Weis,
William V Millar,
Yen Tso Kuo
Jennifer L Johnson's Documents
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more